Regular Article
Dysfunction of Natural Killer Activity in a Family with Chronic Fatigue Syndrome

https://doi.org/10.1006/clin.1998.4554Get rights and content

Abstract

A family was identified with 5 of 6 siblings and 3 other immediate family members who had developed chronic fatigue syndrome (CFS) as adults. All 8 met criteria for the CFS case definition as recommended by the Centers for Disease Control and Prevention. Sixty-eight blood samples were obtained over a period of 2 years from 20 family members (8 affected, 12 unaffected) and 8 normal controls. All blood samples were tested for NK activity in 4-h51Cr-release assays and for the number of circulating CD3–CD56+and CD3–CD16+by flow cytometry. NK activity of the affected immediate family members (cases,n= 8) was significantly lower (P= 0.006, two-sided) than that of the concurrently tested normal controls. The results for unaffected family members were intermediate between these two groups, and the pairwise comparison of unaffected family members to either cases or controls showed no statistically significant difference (P= 0.29, two-sided). No differences were seen between the groups in the absolute number of CD3–CD56+or CD3–CD16+lymphocytes in the peripheral blood. Familial CFS was associated withpersistentlylow NK activity, which was documented in 6/8 cases and in 4/12 unaffected family members. In the family with 5 of 6 siblings who had documented CFS, 2 of their offspring had pediatric malignancies. Low NK activity in this family may be a result of a genetically determined immunologic abnormality predisposing to CFS and cancer.

References (33)

  • T. Aoki et al.

    Low NK syndrome and its relationship to chronic fatigue syndrome

    Clin. Immunol. Immunopathol.

    (1993)
  • S.E. Straus et al.

    Allergy and the chronic fatigue syndrome

    J. Allergy Clin. Immunol.

    (1988)
  • T.L. Whiteside et al.

    Role of natural killer cells in immune surveillance of cancer

    Curr. Opin. Immunol.

    (1995)
  • G.P. Holmes et al.

    Chronic fatigue syndrome: A working case definition

    Ann. Intern. Med.

    (1988)
  • K. Fukuda et al.

    Chronic fatigue syndrome: A comprehensive approach to its definition and study

    Ann. Intern. Med.

    (1994)
  • D.C. Poskanzer et al.

    Epidemic neuromyasthenia: An outbreak in Punta Gorda, Florida

    N. Engl. J. Med.

    (1957)
  • D. Buchwald et al.

    A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpes virus type 6 infection

    Ann. Intern. Med.

    (1992)
  • P.H. Levine et al.

    Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome

    Arch. Intern. Med.

    (1992)
  • P.H. Levine

    Epidemiologic aspects of chronic fatigue syndrome/myalgic encephalomyelitis

    The Clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    (1992)
  • R. Aoki et al.

    Low NK syndrome (LNKS): Clinical and immunologic teachers

    Nat. Immun. Cell Growth Regul.

    (1987)
  • M. Caligiuri et al.

    Phenotypicand functional deficiency of natural killer cells in patients with chronic fatigue syndrome

    J. Immunol.

    (1987)
  • E.A. Ojo-Amaize et al.

    Decreased NK cell activity is associated with severity of chronic fatigue immune dysfunction syndrome

    Clin. Infect. Dis.

    (1994)
  • E. Barker et al.

    Immunologic abnormalities associated with chronic fatigue syndrome

    Clin. Infect. Dis.

    (1994)
  • T.L. Whiteside et al.

    Natural killer cytotoxicity in the diagnosis of immune dysfunction: Criteria for a reproducible assay

    J. Clin. Lab. Anal.

    (1990)
  • H.F. Pross et al.

    Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

    J. Clin. Immunol.

    (1981)
  • J.F. Jones et al.

    Chronic Epstein–Barr virus infection

    Annu. Rev. Med.

    (1987)
  • Cited by (0)

    B. Hyde

    1

    To whom correspondence and reprint requests should be addressed at Viral Epidemiology Branch, National Cancer Institute, EPN 434, Bethesda, MD 20892. Fax: (301) 402-0817.

    View full text